contractor articles (696)
Active Articles:
A50691: Apligraf®A52430: Clinical Trials – Medical Policy Article
A52432: Billing and Coding: Insertion of anterior segment aqueous drainage device, without extraocular reservoir, external approach (0192T 66183)
A52435: Billing and Coding: Osteopathic Manipulative Treatment
A52437: Billing and Coding: Sentinel Lymph Node Biopsy – Medical Policy Article
A52438: Billing and Coding: Tetanus Immunization
A52470: Billing and Coding: Venipuncture Necessitating Physician’s Skill for Specimen Collection – Supplemental Instructions Article
A52535: Process for Determining Self-Administered Drug Exclusions – Medical Policy Article
A52537: Traumeel Injections
A54137: Response to Comments: Intravenous Immune Globulin (IVIG) L35893
A54185: Billing and Coding: MolDX: Afirma™ Assay by Veracyte Update
A54191: Billing and Coding: MolDX: FDA-Approved BRAF Tests
A54192: Billing and Coding: MolDX: FDA-Approved EGFR Tests
A54194: Billing and Coding: MolDX: MammaPrint
A54195: Billing and Coding: MolDX: Oncotype DX® Breast Cancer Assay
A54196: Billing and Coding: MolDX: Oncotype DX® Colon Cancer Assay Update
A54197: Billing and Coding: MolDX: Progensa® PCA3 Assay Coverage Update
A54198: Billing and Coding: MolDX: ResponseDX Tissue of Origin®
A54241: Billing and Coding: MolDX: 4q25-AF Risk Genotype Guidelines
A54243: Billing and Coding: MolDX: CHD7 Gene Analysis Guidelines
A54253: Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency(ASPA) Testing
A54255: Billing and Coding: MolDX: BCKDHB Gene Test
A54256: Billing and Coding: MolDX: BLM Gene Analysis
A54257: Billing and Coding: MolDX: BluePrint® Test
A54262: Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests
A54263: Billing and Coding: MolDX: FANCC Genetic Testing
A54271: Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology
A54274: Billing and Coding: MolDX: L1CAM Gene Sequencing Guidelines
A54277: Billing and Coding: MolDX: MCOLN1 Genetic Testing Guidelines
A54281: Billing and Coding: MolDX: TP53 Gene Test
A54284: Billing and Coding: MolDX: STAT3 Gene Testing
A54285: Billing and Coding: MolDX: SMPD1 Genetic Testing
A54288: Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests Guidelines
A54293: Billing and Coding: MolDX: PAX6 Gene Sequencing Guidelines
A54295: Billing and Coding: MolDX: PIK3CA Gene Tests
A54296: Billing and Coding: MolDX: PreDx®
A54297: Billing and Coding: MolDX: PTCH1 Gene Testing
A54327: Billing and Coding: ArgusM II Retinal Prosthesis System
A54584: Response to Comments: Molecular Diagnostic Tests(MDTs) L36021
A54586: Response to Comments: Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR)
A54588: Response to Comments: MoPath: Special Histochemical Stains and Immunohistochemical Stains
A54607: Response to Comments: MolDx: MGMT Promoter Methylation Analysis DL36113
A54610: Response to Comments for MolDX: Biomarkers in Cardiovascular Risk Assessment
A54611: Response to Comments for MolDX: Breast Cancer Assay: Prosigna
A54612: Response to Comments for MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A54613: Response to Comments for MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A54616: Response to Comments: Prolaris Prostate Cancer Genomic Assay
A54617: Response to Comments: Molecular RBC Phenotyping
A54619: Response to Comments: MolDX: ConfirMDX Epigentic Molecular Assay
A54685: Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing
A54686: Billing and Coding: MolDX: BCR-ABL
A54688: Billing and Coding: MolDX: FDA-Approved KRAS Tests
A54689: Billing and Coding: Germline testing for use of PARP inhibitors
A54777: Response to Comments: Bone Mass Measurement
A54780: Response to Comments: MolDX: Chromosome 1p/19q Deletion Analysis
A54781: Response to Comments: Minimally-Invasive Surgical (MIS) Fusion of Sacroiliac (SI) Joint
A54790: Response to Comments: MolDX: Breast Cancer Assay: Prosigna
A54791: Response to Comments: Repetitive Transcranial magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depression Disorder
A54813: Response to Comments: MolDX: HLA-DQB1 0602 Testing for Narcolepsy
A54814: Response to Comments: MolDX: BRCA1 and BRCA2 Genetic Testing
A54830: Billing and Coding: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)
A54878: Billing and Coding: MolDX: CDH1 Genetic Testing
A54881: Response to Comments: MolDX: HLA-B*15:02 Genetic Testing
A54899: Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment
A54901: Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next Generation Sequencing Testing in Cancer
A54961: Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers – Coding and Billing
A54983: Response to Comments: MolDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A54988: Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment
A55276: Response to Comments: Wound Application of Cellular and/or Tissue Based products (CTPs), Lower Extremities
A55305: Response to Comments: MolDX- CDD: ProMark Risk
A55306: Response to Comments: MolDX-CDD: Decipher® Prostate Cancer Classifier Assay
A55313: Response to Comments: Proton Beam Therapy
A55315: Billing and Coding: Proton Beam Therapy
A55427: Response to Comments: GlycoMark Testing for Glycemic Control
A55430: Response to Comments: Polysomnography and Other Sleep Studies
A55432: Response to Comments: Nerve Conduction Studies and Electromyography
A55435: Response to Comments: MolDX: HLA-DQB1*06:02
A55436: Response to Comments: MolDX - CDD: Oncotype DX ® Breast Cancer for DCIS (Genomic Health ™)
A55451: Response to Comments: Bladder/Urothelial Tumor
A55452: Response to Comments: MolDX: APC and MUTYH Gene
A55453: Response to Comments: MolDX-CDD: Percepta©
A55561: Response to Comments: MolDX DecisionDX Uveal
A55562: Response to Comments: MolDX: Xpresys Lung
A55564: Response to Comments: MolDX: VitaRisk ™ Pharmacogenetic Test for Dry Age-related Macular Degeneration (AMD)
A55566: Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
A55715: Billing and Coding: Coenzyme Q10 (CoQ10)
A55716: Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML)
A55736: Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy
A55835: Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence
A55876: Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression Test
A56050: Billing and Coding: FDA Approved CLL Companion Diagnostic Test
A56083: Billing and Coding: Rezum® System for Benign Prostatic
A56106: Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors
A56142: Response to Comments: MolDX: Corus® CAD Assay
A56148: Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
A56159: Billing and Coding: Frequency of Hemodialysis
A56161: Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
A56175: Low frequency, non-contact, non-thermal ultrasound (CPT code 97610)
A56177: Response to Comments: MolDX: Cystatin C Measurement
A56190: Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A56239: Response to Comments: Frequency of Hemodialysis DL37575
A56283: Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
A56289: Billing and Coding: Therapeutic Apheresis for Familial Hypercholesterolemia
A56313: Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
A56345: Billing and Coding: MolDX: Oncotype DX® Genomic Prostate Score
A56354: Response to Comments: MolDX: MDS FISH
A56366: Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56374: Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
A56424: Billing and Coding: Allergy Immunotherapy
A56425: Billing and Coding: B-type Natriuretic Peptide (BNP) Testing
A56427: Response to Comments: MolDX: myPath Melanoma Assay
A56439: Billing and Coding: Blepharoplasty
A56448: Billing and Coding: Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
A56452: Billing and Coding: Cardiac Event Detection
A56453: Billing and Coding: Cataract Extraction
A56454: Billing and Coding: Cerumen (Earwax) Removal
A56455: Billing and Coding: Chiropractic Services
A56457: Billing and Coding: Corneal Pachymetry
A56459: Billing and Coding: Debridement Services
A56460: Billing and Coding: Dialysis Access Maintenance
A56461: Billing and Coding: Endoscopy by Capsule
A56462: Billing and Coding: Erythropoiesis Stimulating Agents (ESA)
A56464: Billing and Coding: Flow Cytometry
A56465: Billing and Coding: GlycoMark® Testing for Glycemic Control
A56467: Billing and Coding: Laser Ablation of the Prostate
A56471: Billing and Coding: Bladder/Urothelial Tumor Markers
A56472: Billing and Coding: Botulinum Toxins
A56491: Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)
A56493: Billing and Coding: Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy
A56494: Billing and Coding: Cardiovascular Nuclear Medicine
A56496: Response to Comments: MolDX DecisionDx-Melanoma
A56535: Billing and Coding: Minimally-Invasive Surgical (MIS) Fusion of the Sacroiliac (SI) Joint
A56594: Billing and Coding: Panretinal (Scatter) Laser Photocoagulation
A56692: Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
A56696: Billing and Coding: Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities
A56779: Billing and Coding: Intravenous Immune Globulin
A56798: Billing and Coding: Vitamin D Assay Testing
A56800: Billing and Coding: Virtual Colonoscopy (CT Colonography)
A56802: Billing and Coding: Urodynamics
A56809: Billing and Coding: Transesophageal Echocardiography (TEE)
A56811: Billing and Coding: Transcatheter Infusion Therapy
A56816: Billing and Coding: Computerized Corneal Topography
A56818: Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing
A56836: Billing and Coding: Mohs Micrographic Surgery
A56878: Billing and Coding: MolDX: myPath® Melanoma Assay
A56881: Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
A56884: Billing and Coding: MolDX: Breast Cancer Index™ (BCI) Gene Expression Test
A56887: Billing and Coding: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
A56926: Billing and Coding: MDS FISH
A56940: Billing and Coding: MolDX: Prometheus IBD sgi Diagnostic Policy
A56972: Billing and Coding: MolDX: Percepta® Bronchial Genomic Classifier
A56980: Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
A56981: Billing and Coding: MolDX: DecisionDx-UM (Uveal Melanoma)
A56982: Billing and Coding: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
A56983: Billing and Coding: MolDX: MGMT Promoter Methylation Analysis
A56985: Billing and Coding: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56988: Billing and Coding: Cystatin C Measurement
A56989: Billing and Coding: MolDX: Breast Cancer Assay: Prosigna®
A56997: Billing and Coding: MolDX: EndoPredict Breast Cancer Gene Expression Test
A56998: Billing and Coding: MolDX: NRAS Genetic Testing
A56999: Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A57031: Billing and Coding: MolDX: ConfirmMDx Epigenetic Molecular Assay
A57034: Billing and Coding: ProMark® Risk Score
A57038: Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based
A57039: Billing and Coding: Stretta Procedure
A57040: Billing and Coding: Speech-Language Pathology
A57041: Billing and Coding: Somatosensory Testing
A57043: Billing and Coding: RAST Type Tests
A57044: Billing and Coding: Removal of Benign Skin Lesions
A57047: Billing and Coding: Transcranial Magnetic Stimulation (TMS)
A57049: Billing and Coding: Polysomnography and Other Sleep Studies
A57050: Billing and Coding: Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
A57052: Billing and Coding: Psychiatric Inpatient Hospitalization
A57053: Billing and Coding: Psychiatric Partial Hospitalization Programs
A57054: Billing and Coding: Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians
A57065: Billing and Coding: Outpatient Psychiatry and Psychology Services
A57067: Billing and Coding: Outpatient Physical and Occupational Therapy Services
A57068: Billing and Coding: Ocular Photography - External
A57069: Billing and Coding: Ophthalmic Angiography (Fluorescein and Indocyanine Green)
A57132: Billing and Coding: Bone Mass Measurement
A57141: Billing and Coding: MolDX: Repeat Germline Testing
A57149: Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea
A57155: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
A57160: Billing and Coding: Immune Thrombocytopenia (ITP) Therapy
A57165: Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing
A57193: Billing and Coding: Routine Foot Care and Debridement of Nails
A57282: Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
A57284: Billing and Coding: Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation
A57285: Response to Comments: Micro Invasive Glaucome Surgery (MIGS)
A57305: Billing and Coding: Varicose Veins of the Lower Extremity, Treatment of
A57386: Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment
A57663: Billing and Coding: Nerve Blocks for Peripheral Neuropathy
A57870: Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57876: Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors
A57877: Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57910: Billing and Coding: MolDX: Testing of Multiple Genes
A57915: Billing and Coding: MolDX: Pigmented Lesion Assay
A57916: Response to Comments: MolDX: Pigmented Lesion Assay
A57917: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A57918: Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A57926: Billing and Coding: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A57929: Response to Comments: Immune Thrombocytopenia (ITP) Therapy
A57930: Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57994: Billing and Coding: Implantable Automatic Defibrillators
A58038: Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58039: Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58040: Response to Comments: MolDX: Repeat Germline Testing
A58061: Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58063: Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58065: Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58113: Off-Label Use of Drugs and Biologicals for Anti-Cancer Chemotherapeutic Regimen
A58127: Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)
A58178: Response to Comments: MolDX: Pharmacogenomics Testing
A58218: Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58270: Response to Comments: Vitamin D Assay Testing
A58323: Billing and Coding: Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic conditions
A58324: Billing and Coding: MolDX: Pharmacogenomics Testing
A58359: Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A58362: Billing and Coding: Colon Capsule Endoscopy
A58364: Billing and Coding: Facet Joint Interventions for Pain Management
A58368: Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58371: Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58382: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A58398: Response to Comments: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58434: Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
A58452: Response to Comments: MolDX: Blood Product Molecular Antigen Typing
A58462: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
A58463: Response to Comments: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A58480: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A58562: Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing
A58563: Response to Comments: Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic condition
A58582: Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
A58613: Response to Comments: Facet Joint Interventions for Pain Management
A58647: Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test
A58677: MolDX: Algorithm definition as a component of a laboratory test
A58687: Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58706: Billing and Coding: Electroretinography (ERG)
A58708: Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression Test
A58713: Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A58727: Response to Comments: Off-label Use of Rituximab and Rituximab Biosimilars
A58731: Billing and Coding: Epidural Steroid Injections for Pain Management
A58734: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A58735: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58737: Billing and Coding: Platelet Rich Plasma Injections for Non-Wound Injections
A58743: Response to Comments: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58747: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
A58817: Billing and Coding: Influenza Diagnostic Tests
A58894: Response to Comments: Platelet Rich Plasma Injections for Non-Wound Injections
A58899: Response to Comments: Epidural Steroid Procedures Injections for Pain Management
A58916: Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer
A58943: Response to Comments: Electroretinography (ERG)
A59006: Off-Label Use of Chemotherapeutic Drugs and Biologicals for Non-Cancer Indications
A59007: Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
A59063: Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A59066: Billing and Coding: Prostate Cancer Detection with IsoPSA™
A59084: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A59112: Response to Comments: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A59126: Pegfilgrastim (Fulphila; Neulasta; Neulasta Onpro; Nyvepria; Udenyca; Ziextenzo) J2506
A59132: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A59242: Response to Comments: Prostate Cancer Detection with IsoPSA®
A59253: Response to Comments: Transcranial Magnetic Stimulation (TMS)
A59272: Complex Drug Administration Coding
A59287: Response to Comments: Transtelephonic Spirometry
A59289: Response to Comments: Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin